β2-adrenoceptor agonist-induced down-regulation after short-term exposure

被引:8
|
作者
Hardin, AO
Lima, JJ
机构
[1] Ctr Clin Pediat Pharmacol, Nemours Childrens Clin, Jacksonville, FL 32207 USA
[2] Lebonheur Childrens Hosp & Med Ctr, Div Crit Care, Dept Pediat, Memphis, TN 38103 USA
关键词
D O I
10.3109/10799899909042876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the effect of duration of beta(2)-adrenergic receptor (beta(2)AR) occupancy by isoproterenol on specific binding of I-125-lodocyanopindolol (I-125-ICYP) in membranes from rat L6 myoblasts. Ten minute exposure caused a time- and concentration-dependent maximal decrease in I-125-ICYP binding 24 hours after exposure equal to that following continuous exposure (p < 0.05). Low temperature, concanavalin A, H89 and ICI 118,551 blocked the decline in I-125-ICYP binding during the first hour following exposure probably representing receptor sequestration to a compartment or change to a form incapable of ligand binding. Compared to controls, receptor binding 4 and 24 hours following exposure was reduced 56 +/- 8.7% and 72 +/- 8.8%, respectively (p < 0.05), and was blocked by ICI 118,551 but not CGP12177. Isoproterenol-induced, but not forskolin-stimulated, cAMP accumulation was reduced 35% 24 hours following exposure (p < 0.05). I-125-ICYP binding in intact L6 cells 4 and 24 hours after exposure were respectively 56 +/- 8.9 and 61 +/- 13% of controls (p < 0.05). Following agonist exposure, CHO cell membranes expressing human beta(2)ARs exhibited I-125-ICYP binding 85 +/- 2.0% and 6 +/- 2.8% of control values 4 and 24 hours, respectively (p < 0.05). A model predicting that full occupation of the beta(2)AR activates receptor degradation explains our results that agonist-induced downregulation of beta(2)AR does not require continuous presence of the agonist.
引用
收藏
页码:835 / 852
页数:18
相关论文
共 50 条
  • [41] Role of putative phosphorylation sites of histamine H1 receptor in agonist-induced down-regulation
    Horio, S
    Kato, T
    Hisayama, T
    Fujimoto, K
    Fukui, H
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 211P - 211P
  • [42] AGONIST-INDUCED MUSCARINIC ACETYLCHOLINE-RECEPTOR DOWN-REGULATION IN INTACT RAT-BRAIN CELLS
    ELFAKAHANY, EE
    LEE, JH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 132 (01) : 21 - 30
  • [43] AGONIST-INDUCED SUBSTANCE P-RECEPTOR DOWN-REGULATION IN RAT CENTRAL NERVOUS-SYSTEM
    INOUE, A
    TAKEDA, R
    FUKUYASU, T
    NAKATA, Y
    SEGAWA, T
    [J]. PHARMACEUTICAL RESEARCH, 1988, 5 (12) : 795 - 799
  • [44] DESENSITIZATION OF PLATELET-ALPHA-2-ADRENOCEPTORS AFTER SHORT-TERM INFUSIONS OF ADRENOCEPTOR AGONIST IN MAN
    JONES, CR
    GIEMBCYZ, M
    HAMILTON, CA
    RODGER, IW
    WHYTE, K
    DEIGHTON, N
    ELLIOTT, HL
    REID, JL
    [J]. CLINICAL SCIENCE, 1986, 70 (02): : 147 - 153
  • [45] MECHANISM OF ALPHA-2-ADRENOCEPTOR AGONIST-INDUCED DIURESIS
    GELLAI, M
    EDWARDS, RM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (02): : F317 - F323
  • [46] DOWN-REGULATION OF ALPHA-2-ADRENOCEPTOR SUBTYPES
    PLEUS, RC
    SHREVE, PE
    TOEWS, ML
    BYLUND, DB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 244 (02): : 181 - 185
  • [47] Evidence for a role of endogenous GRK3 and GRK2 in agonist-induced down-regulation of the α2B-AR
    Eikenburg, DC
    Desai, AN
    Standifer, KM
    [J]. FASEB JOURNAL, 2005, 19 (05): : A1099 - A1099
  • [48] Delayed agonist-induced desensitization of cardiac functional responses in subjects with the Gln27Glu β2-adrenoceptor polymorphism
    Bruck, H
    Buescher, R
    Ulrich, A
    Radke, J
    Insel, PA
    Brodde, OE
    [J]. CIRCULATION, 2002, 106 (19) : 48 - 49
  • [49] Regulation of aquaporin-2 expression by the α2-adrenoceptor agonist clonidine in the rat
    Junaid, A
    Cui, L
    Penner, SB
    Smyth, DD
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 291 (02): : 920 - 923
  • [50] Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells
    Zhu, JM
    Luo, LY
    Mao, GF
    Ashby, B
    Liu-Chen, LY
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 285 (01): : 28 - 36